Opentrons, whose 11,000-plus robots sit in 90% of top pharma companies, raised a $40 million Series E led by healthcare investor Avego on October 30.
AIHUB
Opentrons Raises $40M to Automate Lab Robots for AI Drug Discovery
Opentrons, a lab automation company with over 11,000 robots deployed in 90% of top pharma companies, raised a $40 million Series E led by healthcare investor Avego on October 30. The funding aims to advance automation of lab robots that support AI-driven drug discovery. This investment underscores the growing intersection of robotics and AI in pharmaceutical research.
The funding event highlights a concrete development in AI-enabled lab automation, relevant to industry watchers tracking AI's role in drug discovery.
Comments & Questions (0)
No comments yet
Be the first to comment!